Boston Biomedical appoints Edgar Braendle as vice president
Dr. Braendle previously served as President and CEO of ARUP Laboratories, a national clinical and anatomic pathology reference laboratory.
Prior to this, Dr. Braendle spent more than a decade at Novartis Pharmaceutical Corporation, where he served as Senior Vice President and Global Head of Companion Diagnostics where he led the company's precision medicine approach, delivering complementary and companion diagnostics for Novartis Medicines.
In an earlier role as Vice President, Global Head of Oncology Biologics, Dr. Braendle led the development of oncology biologics in early to late stages, successfully filing eight investigational new drug applications. ■